Founded in 1986, we have concentrated on the development of enabling
technologies in the areas of gene regulation and gene modification. Many of
our technologies are applicable to the biomedical and pharmaceutical
research markets, and we are further using these technologies as a platform
for our entry into the clinical diagnostics market.
Reta Schmidt – CEO & Founder